US Stock MarketDetailed Quotes

ARGX argenx SE

Watchlist
  • 607.205
  • +3.805+0.63%
Close Dec 13 16:00 ET
  • 607.205
  • 0.0000.00%
Post 16:56 ET
36.31BMarket Cap-778.47P/E (TTM)

About argenx SE Company

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.

Company Profile

SymbolARGX
Company Nameargenx SE
Listing DateMay 18, 2017
Issue Price17.00
Founded2008
CEOMr. Tim Van Hauwermeiren, M. Sc.
MarketNASDAQ
Employees1148
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressLaarderhoogtweg 25
CityAmsterdam
ProvinceNoord-Holland
CountryNetherlands (the)
Zip Code1101 EB
Phone31-76-303-04-88

Company Executives

  • Name
  • Position
  • Salary
  • Tim Van Hauwermeiren, M. Sc.
  • Executive Director and Chief Executive Officer
  • 17.45M
  • Dr. Luc Truyen, M.D.,PhD
  • Chief Medical Officer
  • --
  • Karl Gubitz
  • Chief Financial Officer
  • 4.76M
  • Karen Massey
  • Chief Operating Officer
  • 7.32M
  • Dr. Peter Ulrichts
  • Chief Scientific Officer
  • --
  • Arjen Lemmen
  • Vice President, Corporate Development and Strategy
  • --
  • Peter K.M. Verhaeghe
  • Non-Executive Chairman of the Board
  • 660.33K
  • James M. Daly
  • Independent Director
  • 482.23K
  • Steven E. Krognes
  • Independent Director
  • 635.65K
  • Anthony A. Rosenberg
  • Independent Director
  • 476.82K
  • Dr. Pamela M. Klein, M.D.
  • Independent Director
  • 471.41K
  • Camilla Sylvest
  • Independent Director
  • 365.24K
  • Dr. J. Donald deBethizy, PhD
  • Independent Director
  • 482.23K
  • Dr. Ana Cespedes, PhD
  • Independent Director
  • 261.39K
  • Malini Moorthy
  • General Counsel
  • --
  • Andria Wilk
  • Global Head, Quality
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data